April 23, 2012 — A conclusion reached in a University of North Carolina study was contradicted by a number of peer-reviewed studies that found protons reduce – not increase – gastrointestinal (GI) side effects.

April 23, 2012 - Records exposing the level of medical device recalls made in the United States, and therefore the multitude of serious health risks patients have been subjected to over the past few years, have sparked calls for stricter regulations, according to a new report by healthcare intelligence company GBI Research.

April 20, 2012 — The National Institutes of Health (NIH) awarded a sole source contract for a radiology information system (RIS) to Carestream Health.

April 20, 2012 — GE Healthcare and NXT2B, a privately owned venture capital company, announced they have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and positron emission tomography (PET) tracer production. The three-year development project will be led by GE Healthcare and will be headquartered in Uppsala, Sweden. The terms of the agreement were not disclosed.

April 20, 2012 — Guided Therapeutics Inc. announced this week that the LuViva Advanced Cervical Scan is being introduced to medical leaders at the 40th Anniversary Meeting of the British Society for Colposcopy and Cervical Pathology (BSCCP) in Gateshead, United Kingdom, by Eurosurgical Ltd., the company’s U.K. distributor.

Over the past several years, the radiology community has taken it on the chin with reimbursement cuts to reports of radiation overexposure. Earlier this month, it looked like radiology would be hit again, this time by nine physician societies whose leaders compiled a list of “five things physicians and patients should question” – part of a concerted “Choosing Wisely” campaign launched by organized medicine.

April 19, 2012 — GE Healthcare this week announced it has received U.S. Food and Drug Administration (FDA) clearance of Q.Freeze, one of the positron emission tomography/computed tomography (PET/CT) quantitative imaging technologies designed to enable treatment evaluation earlier in a patient’s cancer treatment.

April 19, 2012 — Carestream Healthcare announced it received U.S. Food and Drug Administration (FDA) clearance for its Carestream DRX-Revolution Mobile X-Ray System, and is now accepting orders from U.S. healthcare facilities.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now